We have shown that alternative splicing of IRF5 is significantly up-regulated in PBMC from SLE patients and that a risk haplotype is associated with the enhanced IRF5 transcript and protein expression (70). This evidence concerns the gene IRF5 and systemic lupus erythematosus.